Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis. 2014

Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
Department of Natural Medicinal Chemistry, China Pharmaceutical University , Nanjing, Jiangsu Province , P.R. China .

Hypericin (Hyp) is newly recognized as a necrosis avid agent, but its poor solubility imposes a great hindrance in clinical application. The aim of this paper was to explore sodium cholate (NaCh) as a potential solvent for Hyp and assess the targetability of (131)I-Hyp in rat necrosis models. Hyp solubility in NaCh solutions was evaluated by equilibrium solubility measurement. Biodistribution of (131)I-Hyp in NaCh solutions and mixed organic solvents was investigated in rat models of liver and muscle necrosis examined with MRI and SPECT/CT in vivo. In addition, pharmacokinetics of (131)I-Hyp in NaCh solutions was studied in healthy rats. Results showed NaCh could improve Hyp solubility and (131)I-Hyp incubated in NaCh solutions/rat plasma was stable up to 120 h. On SPECT/CT images at 24 h post injection, liver infarction location appeared as hot spots. Liver necrosis-to-liver ratios were 12.2, 10.0, 9.6 and 8.2 in 60, 15, 2 mmol/L of NaCh solutions and organic solvents, and muscle necrosis-to-liver ratios were 11.1, 10.1, 7.7 and 7.4, respectively. Pharmacokinetics study revealed t(1/2)z (11.93, 8.96 h, p > 0.05) and AUC (0-∞) (421.21, 553.34 MBq/L h, p < 0.05) of (131)I-Hyp in 2, 60 mmol/L of NaCh solutions, respectively. In conclusion, NaCh was an effective cosolvent, and the necrosis avidity of NaCh-dissolved (131)I-Hyp/Hyp was demonstrated.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010569 Perylene A 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic. Perilene,Peri-Dinaphthalene,Peri Dinaphthalene
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
May 2015, Drug delivery,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
January 2012, Theranostics,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
January 2014, Anti-cancer agents in medicinal chemistry,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
August 2016, Oncotarget,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
February 2014, Pharmaceutical research,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
May 2015, Journal of drug targeting,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
January 2016, Molecular pharmaceutics,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
September 2022, Colloids and surfaces. B, Biointerfaces,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
March 1971, Journal of pharmaceutical sciences,
Yun Ji, and Ying Zhan, and Cuihua Jiang, and Xiao Jiang, and Meng Gao, and Wei Liu, and Yue Li, and Junhu Wang, and Qingqing Wang, and Marlein Miranda Cona, and Nan Yao, and Xiaoning Wang, and Zhijun Fang, and Zhiqi Yin, and Jian Zhang, and Ziping Sun, and Yicheng Ni
May 2014, Oncotarget,
Copied contents to your clipboard!